Remus Pharmaceuticals fundamental analysis
REMUS
642
8.00 (-1.23%)Last updated on 3 Feb, 2026 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Remus Pharmaceuticals Fundamentals
P/E Ratio
26.35
P/B Ratio
2.93
Div. Yield
0.12
Sector P/E
38.5
Sector P/B
2.47
Sec. Div. Yield
84.47
Remus Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 26.35, compared to the sector average of 38.5. Its P/B Ratio stands at 2.93, while the sector’s is 2.47. In terms of returns, the stock offers a Dividend Yield of 0.12%, which is than the sector’s 84.47%.
Remus Pharmaceuticals Score Card
Price
Attractive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Remus Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Remus Pharmaceuticals Associated Pages
- Remus Pharmaceuticals Share Price
- Remus Pharmaceuticals Share Price chart
- Remus Pharmaceuticals Technical Analysis
- Remus Pharmaceuticals Peer Comparison
- Remus Pharmaceuticals Share Price History
- Remus Pharmaceuticals Dividend
- Remus Pharmaceuticals Bonus Share
- Remus Pharmaceuticals Board of Directors
- Remus Pharmaceuticals Shareholding Pattern